酪氨酸激酶抑制剂联合化疗后行异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病与异基因造血干细胞移植治疗Ph(−)急性淋巴细胞白血病的疗效比较

OBJECTIVE: To compare the efficacy of the Ph(+) acute lymphoblastic leukemia (ALL) patients treated with combination of tyrosine kinase inhibitors (TKI) and chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) and Ph(−)ALL patients with allo-HSCT. METHODS: A total...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342638/
https://www.ncbi.nlm.nih.gov/pubmed/26304085
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342638/
https://www.ncbi.nlm.nih.gov/pubmed/26304085
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.014

Ejemplares similares